The current valuation score of Arcutis Biotherapeutics Inc is 7.12, ranking 123 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -1750.98, which is -99.98% below the recent high of -0.42 and -7.15% above the recent low of -1876.14.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.